Stipple Bio CEO Jeff Landau at this year's Endpoints 11 awards (Adam Parshall for Endpoints News)
Lilly has enlisted Cambridge, MA-based startup Stipple Bio for a multibillion-dollar deal to develop new cancer treatments …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







